CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Grant or award Director acquired 24,122 shares (grant or award)
- 4 Grant or award Director acquired 24,122 shares (grant or award)
- 4 Grant or award Director acquired 24,122 shares (grant or award)
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Gift Director gave 40,000 shares (gift)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 1,378 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Legal Off. & Corp. Sec. gave up 1,535 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 6,277 shares (to pay taxes)
- 4 Gift Director gave 80,500 shares (gift)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Principal Accounting Officer gave up 776 shares (to pay taxes)
Page 2 of 25 · 496 filings